CompletedNCT00152035
Safety of SPD465 in Treating Adults With ADHD.
This study is completed. It focuses on ADHD and currently lists study information in Global.
In GlobalADHDOtherFrom 18 Years to 55 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00490542
Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
This study is completed. It focuses on depression and currently lists study information in the United States.
Multiple locations, including ChicagoDepression, BipolarityOtherFrom 18 Years to 65 Years
CompletedNCT04822883
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In Long BeachSchizophreniaOtherFrom 18 Years to 50 Years
CompletedNCT00862992
Safety, Pharmacokinetics and Efficacy Study of MP-214 in people with Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in Japan.
In KureSchizophreniaOtherFrom 20 Years to 65 Years
CompletedNCT00150592
Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
This study is completed in Global. It focuses on ADHD.
In GlobalADHDOtherFrom 6 Years to 17 Years
CompletedNCT00908154
Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.
This study is completed in the United Kingdom. It focuses on Bipolarity.
In LondonBipolarity, DepressionOtherFrom 18 Years to 55 Years
CompletedNCT03327402
Safety study of SHP465 in ADHD
This study is completed in the United States. It is testing SHP465 for ADHD.
Multiple locations, including Little RockADHDOtherFrom 4 Years to 5 Years
WithdrawnNCT03546400
Safety study of Methylphenidate HCl ERCT in ADHD
This study has public registry information in Global. It is testing Methylphenidate HCl ERCT for ADHD.
In GlobalADHDOtherFrom 48 Months to 69 Months
OngoingEUCTR 2015-004587-11
Safety, tolerability and sedative properties of single dose intranasal dexmedetomidine premedication in elderly subjects.
This study is ongoing in Netherlands. It focuses on Anxiety.
In NetherlandsAnxietyOther
CompletedNCT01396447
Safety, Tolerability, and Efficacy of Cariprazine in people with Depression in bipolarity
This study is completed in the United States, in Canada, in Bulgaria, .... It focuses on depression in bipolarity.
Multiple locations, including BirminghamBipolarity, DepressionOtherFrom 18 Years to 65 Years
CompletedNCT06253546
Safety study of TV-44749 in schizophrenia
This study is completed in China. It is testing TV-44749 for schizophrenia.
Multiple locations, including BeijingSchizophreniaOtherFrom 18 Years to 64 Years
CompletedNCT04779177
Safety study of lumateperone in schizophrenia
This study is completed in the United States. It is testing lumateperone for schizophrenia.
Multiple locations, including HollywoodSchizophreniaOtherFrom 13 Years to 17 Years